Close

Publications

Memory B-cell responses to different HPV vaccine regimes: Results from a dose-reduction randomised open-label trial (DoRIS) among Tanzanian school girls up to thirty-six months post-vaccination.
WATSON-JONES, D;
2022
(2022).
Immunobridging single-dose HPV vaccine in Tanzanian girls (DoRIS trial) to Kenyan women in whom single-dose efficacy has been demonstrated (KEN SHE trials).
WATSON-JONES, D;
2022
(2022).
Curable sexually transmitted infections among pregnant women attending antenatal care facilities in low- and middle-income countries between 2000 and 2022: A systematic review and meta-analysis.
Williams, R; AUZENBERGS, M; Linonge-Etombi, C; CLAYTON, TC; Korenromp, E; Rowley, J; Taylor, MM; MABEY, D; CHICO, RM;
2022
(2022).
Bacterial vaginosis among pregnant women attending antenatal care facilities in low- and middle-income countries between 2000 and 2020: A systematic review and meta-analysis.
Park, FJ; Rosca, AS; Cools, P; CHICO, RM;
2022
(2022).
Amuge, P; Lugemwa, A; Wynne, B; Mujuru, HA; Violari, A; Kityo, CM; Archary, M; Variava, E; White, E; Turner, RM; Shakeshaft, C; Ali, S; Nathoo, KJ; Atwine, L; Liberty, A; Bbuye, D; Kaudha, E; Mngqibisa, R; Mosala, M; Mumbiro, V; Nanduudu, A; Ankunda, R; Maseko, L; Kekitiinwa, AR; Giaquinto, C; ... ODYSSEY Trial Team,
2022
The Lancet HIV, (2022).9 9 10.1016/S2352-3018(22)00163-1.
Hamon, JK; Kambanje, M; Pryor, S; Kaponda, AS; Mwale, E; WEBSTER, J; BURCHETT, HE D; MAYHEW, SH;
2022
SSM - Qualitative Research in Health, (2022).2, 10.1016/j.ssmqr.2022.100159.
Gurdasani, D; Pagel, C; MCKEE, M; Michie, S; Greenhalgh, T; Yates, C; Scally, G; Ziauddeen, H;
2022
BMJ, (2022).378, 10.1136/bmj-2022-071234.